Investigating pathways of vancomycin-resistant Enterococcus (VRE) contamination and transmission in intensive care

Tierney O'Sullivan1, Windy D Tanner2, William Brazelton3

  • 1Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT.

Abstract

Insights

Vancomycin-resistant Enterococcus (VRE) spreads between patients in ICUs via healthcare providers and environmental surfaces, even without active outbreaks. Environmental sampling is crucial for understanding VRE transmission potential.

Area of Science:

  • Infectious Diseases
  • Genomics
  • Healthcare Epidemiology

Background:

  • Vancomycin-resistant Enterococcus (VRE) is a significant healthcare-associated pathogen.
  • Patients in intensive care units (ICUs) face a high risk of VRE acquisition.
  • Understanding VRE transmission pathways is critical for effective infection prevention.

Purpose of the Study:

  • To characterize indirect VRE transmission pathways in ICUs using whole genome sequencing.
  • To identify patterns of VRE spread and opportunities for prevention.
  • To evaluate the contribution of environmental and healthcare provider (HCP) sampling to VRE detection.

Main Methods:

  • Collected daily samples from patients, HCP hands, patient rooms, and surfaces in ICUs over 13 weeks.
  • Utilized whole genome sequencing (WGS) for VRE isolate analysis.
  • Employed genomic clustering to identify VRE transmission events and pathways.

Main Results:

  • VRE was detected in 6.22% of occupant-stays, with isolates found on patients, HCP hands, and rooms, but not shared surfaces.
  • Two VRE spread patterns were observed: outbreak-associated and non-outbreak associated with environmental contamination.
  • Including non-patient samples increased VRE detection by 3.3-fold and genomic clusters by 7-fold compared to patient samples alone.

Conclusions:

  • VRE transmission in ICUs is complex, involving movement between occupant-stays facilitated by HCP and environmental contamination.
  • Environmental sampling is essential for a comprehensive understanding of VRE transmission potential.
  • Future research should include post-discharge sampling to accurately assess transmission burdens.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...